Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • Topics
  • Blog
  • Image IQ
MJH Life Sciences

SUBSCRIBE: eNewsletter

T2 Diabetes

GLP-1 agonists quiz

3 Things You (Still) Need to Know About GLP-1 Agonists

July 8, 2015
  • Payal Kohli, MD

Incretin mimetic therapy for type 2 diabetes has been on the market for more than 10 years. Find out what you've learned about the GLP-1 agonists, here.

  • READ >>

SGLT2 Inhibitor Impact on CV Risk: What We Know Now

May 5, 2015

While we wait for results from FDA-mandated CV outcomes studies by SGLT2I makers, there is plenty of (positive) speculation.

  • VIEW NOW >>

Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes

April 27, 2015
  • Grace Halsey

The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.

  • VIEW NOW >>

SGLT2 Inhibitors and Fracture Risk: A Review of What We Know

March 30, 2015
  • Veronica Hackethal, MD

It's probably too early to pass judgment but data from clinical trials point to decreased bone mineral density and increased treatment-emergent fractures in patients taking the new antidiabetes drugs.

  • VIEW NOW >>

Triad of Factors Ups Risk for Type 2 Diabetes

March 27, 2015
  • Sarah Bruyn Jones

New research shows certain women are 43 times more likely to develop type 2 diabetes mellitus after childbirth.

  • READ >>

WHO and How Much Sugar?

March 11, 2015
  • Leo Robert

Evidence-based recommendations on the intake of free sugars to reduce the risk of noncommunicable diseases are the ingredients of a new WHO guideline. Find the recipe in these slides.

  • VIEW NOW >>

Risk of Type 2 Diabetes after GDM Can Be Reduced

March 11, 2015
  • OBGYN.net Staff

Medical and lifestyle interventions successfully lowered the risk of type 2 diabetes in women with a history of gestational diabetes.

  • READ >>
New endocrinology drugs

10 New FDA-Approved Endocrinology Drugs

February 27, 2015
  • Grace Halsey

Since June of 2014, the US FDA has approved a number of drugs for a variety of endocrine-related diseases. Here are 10 of them.

  • VIEW NOW >>

GLP-1 Receptor Agonists and Cardiovascular Outcomes: 3 Studies

February 20, 2015
  • Leah Lawrence

Cardiovascular disease is the underlying cause of death in more than 60% of patients with T2DM. GLP-1 receptor agonists have shown promising cardioprotective effects.

  • VIEW NOW >>

PCOS Ups Health and Hospitalization Risks

February 9, 2015
  • Sarah Bruyn Jones

Women with polycystic ovary syndrome (PCOS) are at increased risk for metabolic and heart diseases and nearly twice as likely to be hospitalized.

  • READ >>

Pages

  • 1
  • 2
  • next ›
  • last »
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".